https://tcd-capital.com/ https://tcd-capital.com/fr https://tcd-capital.com/nl https://tcd-capital.com/about https://tcd-capital.com/fr/about https://tcd-capital.com/nl/about https://tcd-capital.com/team https://tcd-capital.com/fr/team https://tcd-capital.com/nl/team https://tcd-capital.com/internship-application https://tcd-capital.com/fr/internship-application https://tcd-capital.com/nl/internship-application https://tcd-capital.com/investments https://tcd-capital.com/fr/investments https://tcd-capital.com/nl/investments https://tcd-capital.com/services https://tcd-capital.com/fr/services https://tcd-capital.com/nl/services https://tcd-capital.com/services/fund-management https://tcd-capital.com/fr/services/fund-management https://tcd-capital.com/nl/services/fund-management https://tcd-capital.com/services/club-deals https://tcd-capital.com/fr/services/club-deals https://tcd-capital.com/nl/services/club-deals https://tcd-capital.com/services/board-governance https://tcd-capital.com/fr/services/board-governance https://tcd-capital.com/nl/services/board-governance https://tcd-capital.com/news https://tcd-capital.com/fr/news https://tcd-capital.com/nl/news https://tcd-capital.com/contact https://tcd-capital.com/services/club-deals/entrepreneurs https://tcd-capital.com/fr/services/club-deals/entrepreneurs https://tcd-capital.com/nl/services/club-deals/entrepreneurs https://tcd-capital.com/services/club-deals/investors https://tcd-capital.com/fr/services/club-deals/investors https://tcd-capital.com/nl/services/club-deals/investors https://tcd-capital.com/fr/contact https://tcd-capital.com/nl/contact https://tcd-capital.com/pitch https://tcd-capital.com/fr/pitch https://tcd-capital.com/nl/pitch https://tcd-capital.com/investor-contact https://tcd-capital.com/fr/investor-contact https://tcd-capital.com/nl/investor-contact https://tcd-capital.com/spontaneous-application https://tcd-capital.com/fr/spontaneous-application https://tcd-capital.com/nl/spontaneous-application https://tcd-capital.com/privacy-policy https://tcd-capital.com/fr/privacy-policy https://tcd-capital.com/nl/privacy-policy https://tcd-capital.com/cookie-policy https://tcd-capital.com/fr/cookie-policy https://tcd-capital.com/nl/cookie-policy https://tcd-capital.com/investments/lys-therapeutics https://tcd-capital.com/fr/investments/lys-therapeutics https://tcd-capital.com/nl/investments/lys-therapeutics https://tcd-capital.com/investments/vaxinano https://tcd-capital.com/fr/investments/vaxinano https://tcd-capital.com/nl/investments/vaxinano https://tcd-capital.com/investments/clouds-of-care https://tcd-capital.com/fr/investments/clouds-of-care https://tcd-capital.com/nl/investments/clouds-of-care https://tcd-capital.com/investments/myneo https://tcd-capital.com/fr/investments/myneo https://tcd-capital.com/nl/investments/myneo https://tcd-capital.com/investments/inpulse https://tcd-capital.com/fr/investments/inpulse https://tcd-capital.com/nl/investments/inpulse https://tcd-capital.com/investments/synergia-medical https://tcd-capital.com/fr/investments/synergia-medical https://tcd-capital.com/nl/investments/synergia-medical https://tcd-capital.com/investments/univercells https://tcd-capital.com/fr/investments/univercells https://tcd-capital.com/nl/investments/univercells https://tcd-capital.com/investments/smartflats https://tcd-capital.com/fr/investments/smartflats https://tcd-capital.com/nl/investments/smartflats https://tcd-capital.com/investments/vivalto-home https://tcd-capital.com/fr/investments/vivalto-home https://tcd-capital.com/nl/investments/vivalto-home https://tcd-capital.com/investments/flyx-cloud https://tcd-capital.com/fr/investments/flyx-cloud https://tcd-capital.com/nl/investments/flyx-cloud https://tcd-capital.com/investments/sortlist https://tcd-capital.com/fr/investments/sortlist https://tcd-capital.com/nl/investments/sortlist https://tcd-capital.com/investments/3d-side https://tcd-capital.com/fr/investments/3d-side https://tcd-capital.com/nl/investments/3d-side https://tcd-capital.com/investments/bci-pharma https://tcd-capital.com/fr/investments/bci-pharma https://tcd-capital.com/nl/investments/bci-pharma https://tcd-capital.com/investments/dfakto https://tcd-capital.com/fr/investments/dfakto https://tcd-capital.com/nl/investments/dfakto https://tcd-capital.com/investments/graftys https://tcd-capital.com/fr/investments/graftys https://tcd-capital.com/nl/investments/graftys https://tcd-capital.com/investments/lawbox https://tcd-capital.com/fr/investments/lawbox https://tcd-capital.com/nl/investments/lawbox https://tcd-capital.com/investments/yust https://tcd-capital.com/fr/investments/yust https://tcd-capital.com/nl/investments/yust https://tcd-capital.com/investments/tcd-marche https://tcd-capital.com/fr/investments/tcd-marche https://tcd-capital.com/nl/investments/tcd-marche https://tcd-capital.com/team/jean-marc-legrand https://tcd-capital.com/fr/team/jean-marc-legrand https://tcd-capital.com/nl/team/jean-marc-legrand https://tcd-capital.com/team/evrard-de-jonghe https://tcd-capital.com/fr/team/evrard-de-jonghe https://tcd-capital.com/nl/team/evrard-de-jonghe https://tcd-capital.com/team/leri-calvar https://tcd-capital.com/fr/team/leri-calvar https://tcd-capital.com/nl/team/leri-calvar https://tcd-capital.com/team/iago-colera-borras https://tcd-capital.com/fr/team/iago-colera-borras https://tcd-capital.com/nl/team/iago-colera-borras https://tcd-capital.com/esg-policy https://tcd-capital.com/fr/esg-policy https://tcd-capital.com/nl/esg-policy https://tcd-capital.com/glossary https://tcd-capital.com/fr/glossary https://tcd-capital.com/nl/glossary https://tcd-capital.com/services/fund-management/mandate https://tcd-capital.com/fr/services/fund-management/mandate https://tcd-capital.com/nl/services/fund-management/mandate https://tcd-capital.com/services/fund-management/process https://tcd-capital.com/fr/services/fund-management/process https://tcd-capital.com/nl/services/fund-management/process https://tcd-capital.com/team/christophe-florin https://tcd-capital.com/fr/team/christophe-florin https://tcd-capital.com/nl/team/christophe-florin https://tcd-capital.com/team/colette-plasman https://tcd-capital.com/fr/team/colette-plasman https://tcd-capital.com/nl/team/colette-plasman https://tcd-capital.com/team/geoffroy-boonen https://tcd-capital.com/fr/team/geoffroy-boonen https://tcd-capital.com/nl/team/geoffroy-boonen https://tcd-capital.com/team/herve-de-radigues-de-chenneviere https://tcd-capital.com/fr/team/herve-de-radigues-de-chenneviere https://tcd-capital.com/nl/team/herve-de-radigues-de-chenneviere https://tcd-capital.com/team/hubert-bonnet https://tcd-capital.com/fr/team/hubert-bonnet https://tcd-capital.com/nl/team/hubert-bonnet https://tcd-capital.com/team/jean-louis-dubrule https://tcd-capital.com/fr/team/jean-louis-dubrule https://tcd-capital.com/nl/team/jean-louis-dubrule https://tcd-capital.com/team/jean-marc-heynderickx https://tcd-capital.com/fr/team/jean-marc-heynderickx https://tcd-capital.com/nl/team/jean-marc-heynderickx https://tcd-capital.com/team/marc-speeckaert https://tcd-capital.com/fr/team/marc-speeckaert https://tcd-capital.com/nl/team/marc-speeckaert https://tcd-capital.com/team/nicolas-roberti-de-winghe https://tcd-capital.com/fr/team/nicolas-roberti-de-winghe https://tcd-capital.com/nl/team/nicolas-roberti-de-winghe https://tcd-capital.com/team/stephane-verbeeck https://tcd-capital.com/fr/team/stephane-verbeeck https://tcd-capital.com/nl/team/stephane-verbeeck https://tcd-capital.com/team/jean-louis-van-houwe https://tcd-capital.com/fr/team/jean-louis-van-houwe https://tcd-capital.com/nl/team/jean-louis-van-houwe https://tcd-capital.com/team/louis-de-thanhoffer https://tcd-capital.com/fr/team/louis-de-thanhoffer https://tcd-capital.com/nl/team/louis-de-thanhoffer https://tcd-capital.com/news/vaxinano-raises-6m https://tcd-capital.com/fr/news/vaxinano-raises-6m https://tcd-capital.com/nl/news/vaxinano-raises-6m https://tcd-capital.com/news/sortlist-series-b https://tcd-capital.com/fr/news/sortlist-series-b https://tcd-capital.com/nl/news/sortlist-series-b https://tcd-capital.com/news/inpulse-acquired-by-mapal-group https://tcd-capital.com/fr/news/inpulse-acquired-by-mapal-group https://tcd-capital.com/nl/news/inpulse-acquired-by-mapal-group https://tcd-capital.com/news/clouds-of-care-raises-5m https://tcd-capital.com/fr/news/clouds-of-care-raises-5m https://tcd-capital.com/nl/news/clouds-of-care-raises-5m https://tcd-capital.com/news/flyx-cloud-series-a https://tcd-capital.com/fr/news/flyx-cloud-series-a https://tcd-capital.com/nl/news/flyx-cloud-series-a https://tcd-capital.com/news/bci-pharma-acquired-by-gedeon-richter https://tcd-capital.com/fr/news/bci-pharma-acquired-by-gedeon-richter https://tcd-capital.com/nl/news/bci-pharma-acquired-by-gedeon-richter https://tcd-capital.com/news/inpulse-sifted-100-2025 https://tcd-capital.com/fr/news/inpulse-sifted-100-2025 https://tcd-capital.com/nl/news/inpulse-sifted-100-2025 https://tcd-capital.com/news/inpulse-ft1000-2025 https://tcd-capital.com/fr/news/inpulse-ft1000-2025 https://tcd-capital.com/nl/news/inpulse-ft1000-2025 https://tcd-capital.com/news/inpulse-europe-1-interview https://tcd-capital.com/fr/news/inpulse-europe-1-interview https://tcd-capital.com/nl/news/inpulse-europe-1-interview https://tcd-capital.com/news/flyx-cloud-dfs-tsg-samsung https://tcd-capital.com/fr/news/flyx-cloud-dfs-tsg-samsung https://tcd-capital.com/nl/news/flyx-cloud-dfs-tsg-samsung https://tcd-capital.com/news/vaxinano-vaccin-nasal-france-3 https://tcd-capital.com/fr/news/vaxinano-vaccin-nasal-france-3 https://tcd-capital.com/nl/news/vaxinano-vaccin-nasal-france-3 https://tcd-capital.com/news/synergia-neurotech-business-report https://tcd-capital.com/fr/news/synergia-neurotech-business-report https://tcd-capital.com/nl/news/synergia-neurotech-business-report https://tcd-capital.com/news/inpulse-champions-de-la-croissance-2025 https://tcd-capital.com/fr/news/inpulse-champions-de-la-croissance-2025 https://tcd-capital.com/nl/news/inpulse-champions-de-la-croissance-2025 https://tcd-capital.com/news/inpulse-french-ai-report https://tcd-capital.com/fr/news/inpulse-french-ai-report https://tcd-capital.com/nl/news/inpulse-french-ai-report https://tcd-capital.com/news/inpulse-les-echos-portrait https://tcd-capital.com/fr/news/inpulse-les-echos-portrait https://tcd-capital.com/nl/news/inpulse-les-echos-portrait https://tcd-capital.com/news/sortlist-forbes-belgium https://tcd-capital.com/fr/news/sortlist-forbes-belgium https://tcd-capital.com/nl/news/sortlist-forbes-belgium https://tcd-capital.com/news/lys-therapeutics-levee-amorcage https://tcd-capital.com/fr/news/lys-therapeutics-levee-amorcage https://tcd-capital.com/nl/news/lys-therapeutics-levee-amorcage https://tcd-capital.com/news/sortlist-assistant-ia-budgets https://tcd-capital.com/fr/news/sortlist-assistant-ia-budgets https://tcd-capital.com/nl/news/sortlist-assistant-ia-budgets https://tcd-capital.com/news/flyx-cloud-apea-awards https://tcd-capital.com/fr/news/flyx-cloud-apea-awards https://tcd-capital.com/nl/news/flyx-cloud-apea-awards https://tcd-capital.com/news/inpulse-france-2-journal-20h https://tcd-capital.com/fr/news/inpulse-france-2-journal-20h https://tcd-capital.com/nl/news/inpulse-france-2-journal-20h https://tcd-capital.com/news/synergia-premiere-mondiale-implants https://tcd-capital.com/fr/news/synergia-premiere-mondiale-implants https://tcd-capital.com/nl/news/synergia-premiere-mondiale-implants https://tcd-capital.com/news/synergia-first-patients-nao-vns https://tcd-capital.com/fr/news/synergia-first-patients-nao-vns https://tcd-capital.com/nl/news/synergia-first-patients-nao-vns https://tcd-capital.com/news/clouds-of-care-de-tijd https://tcd-capital.com/fr/news/clouds-of-care-de-tijd https://tcd-capital.com/nl/news/clouds-of-care-de-tijd https://tcd-capital.com/news/univercells-exothera-ceo https://tcd-capital.com/fr/news/univercells-exothera-ceo https://tcd-capital.com/nl/news/univercells-exothera-ceo https://tcd-capital.com/news/vaxinano-pairi-daiza https://tcd-capital.com/fr/news/vaxinano-pairi-daiza https://tcd-capital.com/nl/news/vaxinano-pairi-daiza https://tcd-capital.com/news/univercells-nouvelle-identite https://tcd-capital.com/fr/news/univercells-nouvelle-identite https://tcd-capital.com/nl/news/univercells-nouvelle-identite https://tcd-capital.com/news/univercells-technologies-donaldson https://tcd-capital.com/fr/news/univercells-technologies-donaldson https://tcd-capital.com/nl/news/univercells-technologies-donaldson https://tcd-capital.com/news/bci-pharma-gedeon-richter-lecho https://tcd-capital.com/fr/news/bci-pharma-gedeon-richter-lecho https://tcd-capital.com/nl/news/bci-pharma-gedeon-richter-lecho https://tcd-capital.com/news/synergia-scientific-reports https://tcd-capital.com/fr/news/synergia-scientific-reports https://tcd-capital.com/nl/news/synergia-scientific-reports https://tcd-capital.com/news/univercells-serum-institute-of-india https://tcd-capital.com/fr/news/univercells-serum-institute-of-india https://tcd-capital.com/nl/news/univercells-serum-institute-of-india https://tcd-capital.com/news/sortlist-it-ia https://tcd-capital.com/fr/news/sortlist-it-ia https://tcd-capital.com/nl/news/sortlist-it-ia https://tcd-capital.com/news/flyx-cloud-dfs-order-kiosk https://tcd-capital.com/fr/news/flyx-cloud-dfs-order-kiosk https://tcd-capital.com/nl/news/flyx-cloud-dfs-order-kiosk https://tcd-capital.com/news/dfakto-data-vault-certification https://tcd-capital.com/fr/news/dfakto-data-vault-certification https://tcd-capital.com/nl/news/dfakto-data-vault-certification https://tcd-capital.com/news/lys-therapeutics-michel-vounatsos-chairman https://tcd-capital.com/fr/news/lys-therapeutics-michel-vounatsos-chairman https://tcd-capital.com/nl/news/lys-therapeutics-michel-vounatsos-chairman https://tcd-capital.com/news/inpulse-affiches-parisiennes https://tcd-capital.com/fr/news/inpulse-affiches-parisiennes https://tcd-capital.com/nl/news/inpulse-affiches-parisiennes https://tcd-capital.com/news/univercells-hugues-bultot-sudinfo https://tcd-capital.com/fr/news/univercells-hugues-bultot-sudinfo https://tcd-capital.com/nl/news/univercells-hugues-bultot-sudinfo https://tcd-capital.com/news/sortlist-la-libre-2023 https://tcd-capital.com/fr/news/sortlist-la-libre-2023 https://tcd-capital.com/nl/news/sortlist-la-libre-2023 https://tcd-capital.com/news/sortlist-rentabilite-lecho https://tcd-capital.com/fr/news/sortlist-rentabilite-lecho https://tcd-capital.com/nl/news/sortlist-rentabilite-lecho https://tcd-capital.com/news/myneo-medical-genetics-award https://tcd-capital.com/fr/news/myneo-medical-genetics-award https://tcd-capital.com/nl/news/myneo-medical-genetics-award https://tcd-capital.com/news/fund-ii-board-speeckaert-plasman https://tcd-capital.com/fr/news/fund-ii-board-speeckaert-plasman https://tcd-capital.com/nl/news/fund-ii-board-speeckaert-plasman https://tcd-capital.com/news/yust-royal-botanic-bruxelles https://tcd-capital.com/fr/news/yust-royal-botanic-bruxelles https://tcd-capital.com/nl/news/yust-royal-botanic-bruxelles https://tcd-capital.com/news/univercells-andover https://tcd-capital.com/fr/news/univercells-andover https://tcd-capital.com/nl/news/univercells-andover https://tcd-capital.com/news/yust-rooftop-liege https://tcd-capital.com/fr/news/yust-rooftop-liege https://tcd-capital.com/nl/news/yust-rooftop-liege https://tcd-capital.com/news/inpulse-leve-7m https://tcd-capital.com/fr/news/inpulse-leve-7m https://tcd-capital.com/nl/news/inpulse-leve-7m https://tcd-capital.com/news/yust-leve-8m https://tcd-capital.com/fr/news/yust-leve-8m https://tcd-capital.com/nl/news/yust-leve-8m https://tcd-capital.com/legal-notice https://tcd-capital.com/fr/legal-notice https://tcd-capital.com/nl/legal-notice